Save information for later
Sign Up

Learn About Gangliosidosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Gangliosidosis Local Doctors?
Medical Genetics | Endocrinology | Pediatrics
Medical Genetics | Endocrinology | Pediatrics

Duke Health Integrated Practice Inc

40 Duke Medicine Cir, 
Durham, NC 
 (47.3 mi)
Languages Spoken:
English, Arabic, French
Accepting New Patients
Offers Telehealth

Areeg El-Gharbawy is a Medical Genetics specialist and an Endocrinologist in Durham, North Carolina. Dr. El-Gharbawy and is rated as an Experienced provider by MediFind in the treatment of Gangliosidosis. Her top areas of expertise are Von Gierke Disease, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Mitochondrial Trifunctional Protein Deficiency, and Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. Dr. El-Gharbawy is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
What are the latest Gangliosidosis Clinical Trials?
A Natural History Study of the Gangliosidoses

Summary: Hypothesis: To characterize and describe disease progression and heterogeneity of the gangliosidosis diseases. This research study seeks to develop a quantitative method to delineate disease progression for the gangliosidosis diseases (Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis) in order to better understand the natural history and heterogeneity of these diseases. Such a quantitat...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders

Objectives: To study the natural history and progression of neurodegeneration in individuals with glycosphingolipid storage disorders (GSL), GM1 and GM2 gangliosidosis, and glycoprotein (GP) disorders including sialidosis and galactosialidosis using clinical evaluation of patients and patient/parent surveys. To develop sensitive tools for monitoring disease progression. To identify biological markers in blood...